ArticleAlimentary pharmacology & therapeutics2025
Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia-Authors' Reply.
Maral Amangurbanova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.